当前位置:首页 - 行情中心 - 国际医学(000516) - 财务分析 - 现金流量表

国际医学

(000516)

  

流通市值:91.72亿  总市值:93.14亿
流通股本:22.05亿   总股本:22.39亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,080,739,477.451,012,856,058.54,285,911,202.083,153,653,668.29
  收到其他与经营活动有关的现金27,445,996.1313,562,844.3133,316,889.7646,600,111.64
  经营活动现金流入小计2,108,185,473.581,026,418,902.814,319,228,091.843,200,253,779.93
  购买商品、接受劳务支付的现金796,800,751.45302,823,564.721,391,863,199.961,006,477,727.23
  支付给职工以及为职工支付的现金692,973,843.42374,387,250.361,390,276,980.121,071,804,755.69
  支付的各项税费42,907,044.9818,978,379.3672,290,624.654,350,457.97
  支付其他与经营活动有关的现金82,040,795.6680,778,267.05188,327,765.39146,616,983.49
  经营活动现金流出小计1,614,722,435.51776,967,461.493,042,758,570.072,279,249,924.38
  经营活动产生的现金流量净额493,463,038.07249,451,441.321,276,469,521.77921,003,855.55
二、投资活动产生的现金流量:
  收回投资收到的现金15,000,00015,000,00088,919,468.7488,194,869.39
  取得投资收益收到的现金4,083,4324,083,43213,243,897.2717,141.5
  处置固定资产、无形资产和其他长期资产收回的现金净额11,000-34,192,0304,000
  投资活动现金流入小计19,094,43219,083,432136,355,396.0188,216,010.89
  购建固定资产、无形资产和其他长期资产支付的现金100,092,950.1543,324,330.78262,467,565.06234,876,144.3
  投资支付的现金15,000,00015,000,0001,000,000500,000
  投资活动现金流出小计115,092,950.1558,324,330.78263,467,565.06235,376,144.3
  投资活动产生的现金流量净额-95,998,518.15-39,240,898.78-127,112,169.05-147,160,133.41
三、筹资活动产生的现金流量:
  取得借款收到的现金519,850,000344,350,000493,010,000266,310,000
  筹资活动现金流入小计519,850,000344,350,000493,010,000266,310,000
  偿还债务支付的现金1,084,778,121.84556,221,166.641,593,198,433.681,173,669,421.48
  分配股利、利润或偿付利息支付的现金62,903,282.4730,544,411.02149,212,139.12115,948,824.5
  支付其他与筹资活动有关的现金4,000,00014,100,00059,383,755.5256,024,709.86
  筹资活动现金流出小计1,151,681,404.31600,865,577.661,801,794,328.321,345,642,955.84
  筹资活动产生的现金流量净额-631,831,404.31-256,515,577.66-1,308,784,328.32-1,079,332,955.84
五、现金及现金等价物净增加额-234,366,884.39-46,305,035.12-159,426,975.6-305,489,233.7
  加:期初现金及现金等价物余额389,135,027.78389,135,027.78548,562,003.38548,562,003.38
  期末现金及现金等价物余额154,768,143.39342,829,992.66389,135,027.78243,072,769.68
补充资料:
  净利润-116,364,858.26--421,027,140.03-
  资产减值准备-1,453,592.66-2,398,127.54-
  固定资产和投资性房地产折旧298,976,711.11-654,717,326.28-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧298,976,711.11-654,717,326.28-
  无形资产摊销8,657,397.9-33,315,187.67-
  长期待摊费用摊销7,584,720.63-17,113,454.51-
  处置固定资产、无形资产和其他长期资产的损失2,800--177,685.46-
  固定资产报废损失150,927.4-247,546.55-
  公允价值变动损失6,664,822.85-5,975,852.8-
  财务费用64,238,567.64-136,819,875.07-
  投资损失-3,372,820.32--33,957,393.43-
  递延所得税125,819.42-12,493,551.41-
  其中:递延所得税资产减少125,819.42-12,177,654.86-
    递延所得税负债增加--315,896.55-
  存货的减少5,506,375.9-13,776,188.8-
  经营性应收项目的减少46,688,599.7-177,737,207.62-
  经营性应付项目的增加176,912,217.7-695,044,360.83-
  现金的期末余额154,768,143.39-389,135,027.78-
  减:现金的期初余额389,135,027.78-548,562,003.38-
  现金及现金等价物的净增加额-234,366,884.39--159,426,975.6-
公告日期2026-08-212026-04-242026-04-242025-10-30
审计意见(境内)标准无保留意见
TOP↑